Navigation Links
Medifocus, Inc. receives Authorization Approval from Health Canada to launch its pivotal Phase III clinical study of focused microwave heating for treatment of breast cancer in Canada
Date:6/9/2009

VANCOUVER, June 9 /PRNewswire-FirstCall/ - Medifocus, Inc. (TSXV:MFS) is pleased to announce that it has been granted the Investigational Testing Authorization (ITA) from Health Canada's Medical Device Bureau (MDB) for initiating Medifocus' pivotal trial with the Microfocus APA 1000 Breast Thermotherapy System for the treatment of breast cancer. This ITA application has been reviewed by MDB and has fulfilled Part 3 of the Medical Devices Regulations and is now authorized to conduct the pivotal trial in Canada. ITA is similar to the "No Objection Letter" issued by the Therapeutics Product Directorate for pharmaceutical products.

The Company's pivotal clinical trial is designed to assess the safety and improvement in efficacy, as measured by increased tumor shrinkage, using its focused microwave heat energy in combination with neo-adjuvant chemotherapy over chemotherapy alone on large breast cancer tumor. The full ITA approval was obtained after the Research Ethics Boards (REB) of the Ville Marie Medical Center and of the St. Mary's Hospital in Montreal, both granted clearance to begin the pivotal study. Ville Marie is one of the most active comprehensive breast cancer centers in Quebec and the St. Mary's Hospital is a teaching hospital of the McGill University. Dr. Kyserlingk, the director of Ville Marie Medical Center, will be the principal investigator in Canada for the pivotal study. A total of 238 patients will be entered into the study.

The basis of this ITA-approved pivotal study was from the data analyzed from an FDA allowed phase II multi-center randomized study using the Microfocus APA 1000 Thermotherapy System on large breast tumors. The data showed that the median tumor shrinkage in the Thermo-chemo arm was 88.4% and for the Chemotherapy alone arm the median tumor shrinkage was only 58.8%. This increase in median tumor shrinkage was statistically significant with a P value equal to 0.048. In addition, the data indicated th
'/>"/>

SOURCE Medifocus Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... ... assistance company today announced that it has entered into a multi-year agreement with ... an agreement to bridge the link between American healthcare, Jamaican healthcare and Health ...
(Date:9/3/2015)... ... September 03, 2015 , ... TransPack Toon gives users a set of ... wipes and framing transitions in 30 different styles. Presets range from snow, underwater, forest, ... X. , TransPack Toon features 90 cartoon transitions from 30 unique styles. Editors ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... in Patient Experience Conference 2016, to be held April 13-15 at Sheraton Hotel ... hosted event bringing together the collective voices of healthcare leaders, staff, physicians, patients ...
(Date:9/3/2015)... ... September 03, 2015 , ... Results of a comprehensive survey ... and Policy Analysis has found physician leadership development training programs to be growing ... respondents said their organizations conduct some kind of physician leadership development program, another ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... graduated compression garments. However, graduated compression garments are an effective solution for reducing ... specialist, Robyn Bjork, was recently sponsored by SIGVARIS for a unique ...
Breaking Medicine News(10 mins):Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:Survey finds growing movement for physician leadership training 2Health News:Survey finds growing movement for physician leadership training 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3
... , ST. PAUL, Minn., Dec. 7 Securian,s IncomeToday! ... now available on the CANNEX SPIA Exchange. , IncomeToday! ... feature called the Advance Withdrawal Benefit. This feature allows clients ... future annuity income stream, making IncomeToday! a fixed ...
... Two medications approved as treatment for drug-resistant chronic myeloid ... as a first treatment than the existing front-line drug, ... Cancer Center reported at the 51st Annual Meeting of ... CML remains imatinib, a Novartis drug known as Gleevec, ...
... WASHINGTON People who drink may want to know ... laboratory research. Instead, a cup of coffee may make ... What,s more, popular caffeinated "alcohol-energy" drinks don,t neutralize ... reported in the journal Behavioral Neuroscience , which ...
... to demonstrate a clear positive association between adolescent fitness ... of Southern California and colleagues in Sweden find that ... scores on a range of intelligence tests and ... early adolescence and adulthood, the central nervous system displays ...
... ... of Kayentis, attended the roundtable discussion organized by Governor of Massachusetts Deval Patrick about ... ... CEO of Kayentis, attended the roundtable discussion organized by Governor of Massachusetts Deval Patrick ...
... Study found pregnant mice that inhaled barnyard air passed ... -- Children born to mothers exposed to microbes during ... researchers say. , They found that pregnant mice exposed ... The microbe exposure triggered a mild inflammatory response in ...
Cached Medicine News:Health News:IncomeToday! Securian's Minnesota Life/SPIA Product Added to CANNEX Exchange 2Health News:Second-line CML drugs evoke faster response than front-line therapy 2Health News:Caffeine doesn't reverse the negative cognitive impact of alcohol, study shows 2Health News:Caffeine doesn't reverse the negative cognitive impact of alcohol, study shows 3Health News:Fit teenage boys are smarter 2Health News:Kayentis Attended the Roundtable Discussion About HIT Adoption Organized By the Governor of Massachusetts 2Health News:Kayentis Attended the Roundtable Discussion About HIT Adoption Organized By the Governor of Massachusetts 3Health News:Mom's Exposure to Microbes Lowers Allergies in Kids 2
(Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/sd9xxh/radiology ) ... Systems Market by Type, Deployment Mode, End User and ... report to their offering. The ... Million 2014, and is projected to reach $722.7 Million ... to 2019. The global radiology information ...
(Date:9/3/2015)... Sept. 3, 2015 HeartWare International, Inc ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... its President and Chief Executive Officer, Doug Godshall ... Fargo Healthcare Conference at 8:50 a.m. ET on Wednesday, ... 2015 at The Hyatt Regency, Boston ...
(Date:9/3/2015)... , Sept. 3, 2015  Four financial reasons ... white paper released by Leaf Healthcare, Inc ... Healthcare Research & Quality (AHRQ), pressure ulcers ... billion annually . In addition to direct treatment ... government penalties, and negatively impact hospital performance metrics. ...
Breaking Medicine Technology:Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 3HeartWare Presentation At The 2015 Wells Fargo Healthcare Conference To Be Webcast 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 3
... Combination Therapy Significantly Decreased Tumor Blood Vessel,Density ... -, LOS ANGELES and TUSTIN, Calif., April ... a,clinical stage biopharmaceutical company developing targeted,monoclonal antibodies ... C,virus (HCV) infection, today announced that preclinical ...
... 2007 /PRNewswire/ -- Researchers from the,Barbara Ann Karmanos ... that an antibiotic typically prescribed for,Alzheimer's patients could ... , Q. Ping Dou, Ph.D., leader, Prevention Program ... findings of their study showing,that the drug Clioquinol ...
Cached Medicine Technology:Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 2Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 3Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 4Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 5Alzheimer's Drug Shows Promise in Fighting Cancer 2
The Nine West Eyewear collection is positioned to present today's styles with a sharp, edgy contemporary attitude tied into a clean design element....
The Liz Claiborne eyewear collection features feminine, classic, progressive friendly designs that meet the needs of today's women. The high quality frames are modern, but not trendy....
Inquire...
... inspired by the professional male who enjoys buying ... by all men especially those between the ages ... complete range of materials, shapes and colors. Classic ... the best that fashion and technology has to ...
Medicine Products: